免疫接种后感音神经性听力损失(SNHL)病例定义与免疫安全数据指南
本文是Brighton协作组关于免疫接种后不良事件(AEFI)中「感音神经性听力损失」的病例定义。该定义由流行病防范创新联盟(CEPI)召集的专家组制定,遵循Brighton协作组格式,经文献综述和专家咨询形成共识定义及诊断确定性分级,并经过Brighton协作网络同行评议。
要点
- 提供免疫接种后SNHL的标准化病例定义与诊断确定性分级。
- 定义由CEPI召集专家组制定,针对拉沙热等新发病原疫苗开发背景。
- 遵循Brighton协作组方法,经文献综述、专家咨询和同行评议。
核心结论
- 建立免疫接种后感音神经性听力损失的共识性病例定义及诊断确定性分级,用于AEFI评价。
研究设计与样本
- 由CEPI召集的专家组制定,遵循Brighton协作组病例定义格式,经文献综述和专家咨询形成共识,并由Brighton协作网络同行评议。
关键数值与推荐
- 病例定义包含诊断确定性分级,具体分级标准见原文。
临床怎么用
- 在免疫安全监测中采用该标准化病例定义评价接种后SNHL不良事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This is a Brighton Collaboration case definition of the term "Sensorineural Hearing Loss" to be utilized in the evaluation of adverse events following immunization. The case definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for Lassa Fever and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and define levels of diagnostic certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network.
引用
- Carol Liu YC, Ibekwe T, Kelso JM, et al. Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2020. PMID: 32418788. doi:10.1016/j.vaccine.2020.05.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。